Open Label Safety Study of Enteric-Coated Spheroid Suspension in Infants Aged Less Than 12 Months With Presumed Gastroesophageal Reflux Disease (GERD)

ClinicalTrials.gov ID: NCT00868296

Public ClinicalTrials.gov record NCT00868296. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Oct 22, 2026, 9:35 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Muliticenter, Open Label Safety Study of 2 Doses of Pantoprazole Sodium Enteric-Coated Spheroid Suspension in Infants Aged Less Than 12 Months With Presumed GERD

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to provide additional information on safety and tolerability after multiple does of pantoprazole. Only patients who successfully completed the 3001B3-331 study (NCT00362609) or 3001B3-333 study (NCT00259012) are eligible to participate in this study.

Study identification

NCT ID: NCT00868296
Recruitment status: Completed
Study type: Interventional
Phase: Phase 3
Lead sponsor: Wyeth is now a wholly owned subsidiary of Pfizer; Industry
Enrollment: 58 participants

Conditions and interventions

Conditions

Gastroesophageal Reflux

Interventions

pantoprazole Drug

Drug

Eligibility (public fields only)

Age range: 1 Day to 12 Months
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Mar 2006 (Type not available)
Primary completion: Mar 2008 (Actual)
Completion: Mar 2008 (Actual)
Last update posted: May 4, 2010

2006 – 2008

United States locations

U.S. sites: 45
U.S. states: 28
U.S. cities: 45

Facility	City	State	ZIP	Site status
Not listed	Phoenix	Arizona	85006	—
Not listed	Loma Linda	California	92354	—
Not listed	Oakland	California	94609-1809	—
Not listed	Orange	California	92868	—
Not listed	Sacramento	California	95817	—
Not listed	San Diego	California	92103	—
Not listed	New Haven	Connecticut	06520-8064	—
Not listed	Washington D.C.	District of Columbia	20010	—
Not listed	Gainesville	Florida	32610-0296	—
Not listed	Miami	Florida	33101	—
Not listed	Sunrise	Florida	33323	—
Not listed	Atlanta	Georgia	30322	—
Not listed	Honolulu	Hawaii	96826	—
Not listed	Boise	Idaho	83704	—
Not listed	Chicago	Illinois	60614	—
Not listed	Park Ridge	Illinois	60068	—
Not listed	Lexington	Kentucky	40536-0284	—
Not listed	Louisville	Kentucky	40202	—
Not listed	New Orleans	Louisiana	70121	—
Not listed	Baltimore	Maryland	21201	—
Not listed	Boston	Massachusetts	02114	—
Not listed	Flint	Michigan	48503	—
Not listed	Omaha	Nebraska	68105	—
Not listed	Camden	New Jersey	08103	—
Not listed	New Brunswick	New Jersey	08901	—
Not listed	Newark	New Jersey	07103	—
Not listed	Albany	New York	12208	—
Not listed	Brooklyn	New York	11219	—
Not listed	New York	New York	10032	—
Not listed	The Bronx	New York	10467	—
Not listed	Valhalla	New York	10595-1689	—
Not listed	Durham	North Carolina	27710	—
Not listed	Winston-Salem	North Carolina	27157	—
Not listed	Oklahoma City	Oklahoma	73104	—
Not listed	Portland	Oregon	97239-3042	—
Not listed	Danville	Pennsylvania	17822-1320	—
Not listed	Memphis	Tennessee	38163	—
Not listed	Nashville	Tennessee	37232-9550	—
Not listed	Dallas	Texas	75390-9063	—
Not listed	San Antonio	Texas	78229	—
Not listed	Salt Lake City	Utah	84113	—
Not listed	Burlington	Vermont	05401	—
Not listed	Richmond	Virginia	23298	—
Not listed	Morgantown	West Virginia	26506	—
Not listed	Milwaukee	Wisconsin	53226	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 26 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00868296, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted May 4, 2010 · Synced Oct 22, 2026

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00868296 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →